How a Stanford aging biologist invests in longevity

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/e3/66/fd/e366fda9-13c2-0ebc-7816-2844fa29d947/mza_9015250144079839153.jpg/600x600bb.jpg

Free Radicals

Daniel Shur and Eric Dai

2 episodes

2 days ago

Interviewing visionaries dedicated to giving humanity control over biology. All problems are solvable, including aging and death.

Life Sciences

Science

RSS

All content for Free Radicals is the property of Daniel Shur and Eric Dai and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Interviewing visionaries dedicated to giving humanity control over biology. All problems are solvable, including aging and death.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/44142755/44142755-1763427468732-7a584148b3c73.jpg

How a Stanford aging biologist invests in longevity - Dr. Alex Colville

Free Radicals

1 hour 21 minutes 5 seconds

3 days ago

How a Stanford aging biologist invests in longevity - Dr. Alex Colville

Alex Colville, PhD, is a Co-founder and General Partner at Age1, one of the premier aging venture capital firms where he has invested in companies like Science, Gordian, Loyal, and General Control. Prior to that, he was an investor and founding chief of staff at Amaranth Foundation, where he invested in moonshot biology and aging initiatives. He got his biotech business career started as a management consultant at Putnam Associates and as a consultant to the Maze Therapeutics BD team and Rubedo Life Sciences R&D team. Alex earned his PhD at Stanford in the biology of aging.